VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MET
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
METMetLife, Inc.
$98.27$63.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. MET
  4. Financial Ratios

MetLife, Inc. (MET) Financial Ratios

Latest Ratios: P/E Ratio 12.3x · EV/EBITDA 7.9x · ROE 11.9%. (1998–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

MET Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$63.2B$52.5B$58.2B$50.4B$58.5B$54.3B$42.9B$48.1B$41.6B$52.8B$52.6B
Enterprise Value$61.4B$50.6B$56.9B$48.6B$56.3B$51.7B$41.2B$48.4B$42.1B$59.4B$59.8B
P/E Ratio →12.2716.4513.7836.5411.498.178.278.418.3613.5271.67
P/S Ratio0.770.680.830.740.860.860.630.690.610.850.87
P/B Ratio2.261.822.101.671.940.800.570.730.790.900.78
P/FCF4.212.903.853.545.154.243.733.464.374.153.59
P/OCF3.492.903.853.545.154.243.733.464.374.153.59

P/E links to full P/E history page with 30-year chart

MET EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.660.810.720.830.820.610.700.620.950.99
EV / EBITDA7.909.358.9816.888.005.615.466.526.0613.7112.12
EV / EBIT13.178.858.5415.167.715.485.266.245.6612.7311.00
EV / FCF—2.803.763.414.954.033.583.474.414.674.08

MET Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin36.4%36.4%27.2%25.5%27.9%26.6%22.8%23.3%23.4%21.6%23.1%
Operating Margin6.0%6.0%8.0%3.2%9.4%13.4%10.2%9.8%9.3%5.7%7.1%
Net Profit Margin4.4%4.4%6.3%2.3%7.8%10.8%8.0%8.5%7.5%6.4%1.4%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE11.9%11.9%15.3%5.2%10.8%9.6%7.7%9.9%9.2%6.3%1.2%
ROA0.5%0.5%0.6%0.2%0.7%0.9%0.7%0.8%0.7%0.5%0.1%
ROIC13.1%13.1%15.4%5.8%10.3%9.2%7.4%8.5%8.0%3.8%4.2%
ROCE1.0%1.0%1.3%0.5%1.4%1.7%0.9%1.0%0.9%0.4%0.5%

MET Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.700.700.680.620.600.260.240.250.310.330.29
Debt / EBITDA3.733.732.956.542.561.892.412.272.344.464.02
Net Debt / Equity—-0.06-0.05-0.06-0.07-0.04-0.020.000.010.110.11
Net Debt / EBITDA-0.34-0.34-0.21-0.63-0.31-0.28-0.220.030.061.531.46
Debt / FCF—-0.10-0.09-0.13-0.19-0.20-0.140.020.040.520.49
Interest Coverage5.395.396.423.077.7810.268.598.126.624.134.70

Net cash position: cash ($22.0B) exceeds total debt ($20.2B)

MET Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio0.650.650.551.361.341.47—————
Quick Ratio0.650.650.551.361.341.47—————
Cash Ratio0.450.450.421.231.251.40—————
Asset Turnover—0.100.100.100.100.080.090.090.100.090.07
Inventory Turnover———————————
Days Sales Outstanding———————————

MET Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield2.3%2.9%2.6%3.1%2.7%3.0%3.9%3.4%4.0%3.3%3.3%
Payout Ratio44.7%44.7%34.5%99.2%30.2%24.0%30.6%27.9%32.8%42.8%204.2%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield8.2%6.1%7.3%2.7%8.7%12.2%12.1%11.9%12.0%7.4%1.4%
FCF Yield23.7%34.5%26.0%28.3%19.4%23.6%26.8%28.9%22.9%24.1%27.9%
Buyback Yield6.1%7.4%5.5%6.2%5.7%8.8%5.0%4.7%9.6%5.5%0.7%
Total Shareholder Yield8.5%10.3%8.1%9.3%8.4%11.9%8.9%8.2%13.6%8.8%4.0%
Shares Outstanding—$665M$711M$762M$809M$869M$913M$944M$1.0B$1.0B$1.1B

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Volatile underwriting and rate sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Combined Ratio Swings Keep Underwriting Thin

Based on reported quarterly figures, MetLife's combined ratio moved from 95.3% in Q4 2025 to 84.0% in Q3 2026, showing underwriting profitability that is real but highly sensitive to benefit cost timing across quarters.

The swing in the combined ratio is driven mainly by the loss ratio, which ranged from 62.8% to 85.2% over the period, while expense ratio volatility from 9.3% to 29.3% suggests the quarterly figures may partly reflect accounting timing rather than a durable efficiency shift. A sub-95% combined ratio in the most recent quarter is encouraging, but a single favorable print does not establish a trend, and investors should monitor whether the loss ratio stabilizes below roughly 70%.

Discount to Book Reflects Earnings Uncertainty

At a P/B of 2.26 and a trailing P/E of 12.27, MetLife trades near the middle of its peer range, with forward P/E of 9.62 implying the market expects earnings to improve from current levels.

Relative to Prudential at 1.17 times book and Principal at 2.02, MetLife's book multiple appears justified by its scale in U.S. group benefits, though the book value itself is a function of invested assets backing reserves rather than franchise earnings power. The gap between trailing and forward P/E suggests the market is pricing a recovery in reported earnings, which would need to be validated by sustained underwriting results before the premium can be treated as durable.

ROE Depends on Underwriting Not Float Yield

Reported ROE of 9.5% in Q3 2026 compares with a range of 2.6% to 4.6% across prior quarters, and the step-up appears more closely linked to the improved combined ratio than to investment income.

Decomposing the return, the underwriting margin rose from 4.7% to 16.0% over the period, which accounts for most of the ROE improvement, while ROA remained near 0.1% to 0.3% because the asset base is large relative to earnings. Investment yield on the float is the stabilizing component, but investment income data is not reliably populated here, so the split between underwriting and investment contribution cannot be fully verified.

Thin Equity Cushion Against Policyholder Obligations

According to reported figures, MetLife's equity of $22.2B against $721.9B of liabilities in Q3 2026 leaves a narrow capital buffer, with debt-to-equity rising from 0.60 to 0.95 over the period.

The rise in debt-to-equity alongside a flat-to-lower equity base suggests that balance sheet growth is being funded more by liabilities than by retained capital, which warrants monitoring of capital adequacy relative to rating agency expectations. Interest coverage improved to 11.31 in the latest quarter, a constructive signal, but the leverage trend means the capital base has less room to absorb a sustained adverse claims or market cycle.

Combined Ratio Overstates Quarterly Stability

The most commonly misapplied metric here is the single-quarter combined ratio, which can mask reserve development and benefit timing that the reported figures alone do not disentangle.

A combined ratio of 84.0% in one quarter may reflect favorable reserve releases or benefit timing rather than a structural improvement in underwriting, and the ten-quarter range from 84.0% to 95.3% argues against treating any single print as representative. A more reliable approach would be to use a trailing twelve-month combined ratio adjusted for reserve development, alongside an earnings measure that separates the MetLife Holdings run-off segment from the core business.

Download Financial Ratios Data

Includes 30+ ratios · 28 years · Updated daily

Consensus & Technical Research Suite
Open MET Terminal

MET Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MET — Frequently Asked Questions

Quick answers to the most common questions about buying MET stock.

What is MetLife, Inc.'s P/E ratio?

MetLife, Inc.'s current P/E ratio is 12.3x. The historical average is 16.2x. This places it at the 60th percentile of its historical range.

What is MetLife, Inc.'s EV/EBITDA?

MetLife, Inc.'s current EV/EBITDA is 7.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.3x.

What is MetLife, Inc.'s ROE?

MetLife, Inc.'s return on equity (ROE) is 11.9%. The historical average is 8.5%.

Is MET stock overvalued?

Based on historical data, MetLife, Inc. is trading at a P/E of 12.3x. This is at the 60th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is MetLife, Inc.'s dividend yield?

MetLife, Inc.'s current dividend yield is 2.31% with a payout ratio of 44.7%.

What are MetLife, Inc.'s profit margins?

MetLife, Inc. has 36.4% gross margin and 6.0% operating margin.

How much debt does MetLife, Inc. have?

MetLife, Inc.'s Debt/EBITDA ratio is 3.7x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.